1. Home
  2. BRCB vs ABCL Comparison

BRCB vs ABCL Comparison

Compare BRCB & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRCB
  • ABCL
  • Stock Information
  • Founded
  • BRCB 2008
  • ABCL 2012
  • Country
  • BRCB United States
  • ABCL Canada
  • Employees
  • BRCB N/A
  • ABCL N/A
  • Industry
  • BRCB
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRCB
  • ABCL Health Care
  • Exchange
  • BRCB Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • BRCB 1.3B
  • ABCL 1.1B
  • IPO Year
  • BRCB 2025
  • ABCL 2020
  • Fundamental
  • Price
  • BRCB $27.75
  • ABCL $4.57
  • Analyst Decision
  • BRCB
  • ABCL Strong Buy
  • Analyst Count
  • BRCB 0
  • ABCL 5
  • Target Price
  • BRCB N/A
  • ABCL $8.00
  • AVG Volume (30 Days)
  • BRCB 2.4M
  • ABCL 3.8M
  • Earning Date
  • BRCB 01-01-0001
  • ABCL 11-03-2025
  • Dividend Yield
  • BRCB N/A
  • ABCL N/A
  • EPS Growth
  • BRCB N/A
  • ABCL N/A
  • EPS
  • BRCB N/A
  • ABCL N/A
  • Revenue
  • BRCB $160,917,000.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • BRCB N/A
  • ABCL $15.60
  • Revenue Next Year
  • BRCB N/A
  • ABCL $65.70
  • P/E Ratio
  • BRCB N/A
  • ABCL N/A
  • Revenue Growth
  • BRCB 20.84
  • ABCL N/A
  • 52 Week Low
  • BRCB $25.05
  • ABCL $1.89
  • 52 Week High
  • BRCB $30.40
  • ABCL $5.82
  • Technical
  • Relative Strength Index (RSI)
  • BRCB N/A
  • ABCL 55.44
  • Support Level
  • BRCB N/A
  • ABCL $4.32
  • Resistance Level
  • BRCB N/A
  • ABCL $4.85
  • Average True Range (ATR)
  • BRCB 0.00
  • ABCL 0.28
  • MACD
  • BRCB 0.00
  • ABCL 0.04
  • Stochastic Oscillator
  • BRCB 0.00
  • ABCL 72.55

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: